CoraLite® Plus 488-conjugated CD133 Monoclonal antibody
CD133 Monoclonal Antibody for
Host / Isotype
Mouse / IgG1
Reactivity
Human and More (1)
Applications
Conjugate
CoraLite® Plus 488 Fluorescent Dye
CloneNo.
2B8A2
Cat no : CL488-66666
Synonyms
Validation Data Gallery
Product Information
CL488-66666 targets CD133 in applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Cited Reactivity | human |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Immunogen | CD133 fusion protein Ag13327 |
Full Name | prominin 1 |
Calculated Molecular Weight | 97 kDa |
Observed Molecular Weight | 115 kDa, 80-90 kDa |
GenBank Accession Number | BC012089 |
Gene Symbol | CD133 |
Gene ID (NCBI) | 8842 |
Conjugate | CoraLite® Plus 488 Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 493 nm / 522 nm |
Form | Liquid |
Purification Method | Protein G purification |
Storage Buffer | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
Storage Conditions | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
CD133, also known as PROM1 (prominin-1) or AC133, belongs to the prominin family. CD133 is a transmembrane glycoprotein with an NH2-terminal extracellular domain, five transmembrane loops and a cytoplasmic tail. The expression of CD133 has been reported in hematopoietic stem cells, endothelial progenitor cells, neuronal and glial stem cells, suggesting the potential role of CD133 as a cell surface marker of adult stem cells. CD133 has also been reported as a marker of cancer stem cells in various human tumors. CD133 is a highly glycosylated protein with an apparent molecular weight of 115-120 kDa. After the treatment of the lysates with glycosidase, CD133 shifted to a protein with an apparent molecular weight of 80-90 kDa (PMID: 23150174; 20068153).
Publications
Species | Application | Title |
---|---|---|
J Cancer Linc00662 sponges miR-15b-5p to promote hypopharyngeal squamous cell carcinoma progression by facilitating cancer stem cell-like phenotypes |